News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Scientists at The Institute of Cancer Research, London, are calling for targeted screening after finding…
The ESMO Congress 2025 has seen pivotal studies unveiling compelling evidence that a new class of…
Results from a trial presented at ESMO 205 have shown that a targeted therapy combination improved…
A multicenter Phase II clinical trial has demonstrated significant tumour shrinkage and disease control in patients…
Patients with oestrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with…
Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful…
A drug that harnesses the immune system to attack cancer cells has proved successful in…
A sneak preview podcast of what to expect from the AGITG’s 2025 ASM!
Researchers have demonstrated that pulsed low dose rate (PLDR) chemoradiation therapy can significantly reduce side effects while…
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy…